首页> 美国卫生研究院文献>Journal of Virology >Human Immunodeficiency Virus Type 1-Derived Lentivirus Vectors Pseudotyped with Envelope Glycoproteins Derived from Ross River Virus and Semliki Forest Virus
【2h】

Human Immunodeficiency Virus Type 1-Derived Lentivirus Vectors Pseudotyped with Envelope Glycoproteins Derived from Ross River Virus and Semliki Forest Virus

机译:人免疫缺陷病毒1型慢病毒载体与罗斯河病毒和Semliki森林病毒衍生的包膜糖蛋白假型化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ross River virus (RRV) and Semliki Forest virus (SFV) are two alphaviruses that have a high degree of amino acid homology, as well as a very broad host range. We show here that envelope glycoproteins derived from both viruses can pseudotype human immunodeficiency virus type 1 (HIV-1)-derived lentivirus vectors. Both RRV and SFV glycoproteins considerably expand the host range of the lentivirus vector, and vectors can be efficiently concentrated by ultracentrifugation. A systematic analysis comparing the alphaviral glycoproteins to the vesicular stomatitis virus glycoprotein (VSV-G) revealed that lentivirus vectors incorporate RRV glycoproteins with an efficiency comparable to that of VSV-G. Both pseudotypes have comparable physical titers, but infectious titers with the RRV pseudotype are lower than with VSV-G. Incorporation of SFV glycoproteins into lentivirus vector is less efficient, leading to decreased physical and infectious titers. The transduction rates with VSV-G-, RRV-, and SFV-pseudotyped lentivirus vectors into adherent cell lines can be significantly increased by using a combination of Polybrene and plates coated with CH-296 recombinant fibronectin fragments. Together, our data suggest that RRV and SFV glycoproteins might be suitable as alternatives to VSV-G for pseudotyping lentivirus vectors.
机译:罗斯河病毒(RRV)和塞姆利基森林病毒(SFV)是两种具有高度氨基酸同源性且宿主范围非常广的alpha病毒。我们在这里显示了两种病毒的包膜糖蛋白可以假型人类免疫缺陷病毒1型(HIV-1)衍生的慢病毒载体。 RRV和SFV糖蛋白都大大扩展了慢病毒载体的宿主范围,并且可以通过超速离心有效地浓缩载体。系统分析比较了α病毒糖蛋白和水泡性口炎病毒糖蛋白(VSV-G),发现慢病毒载体掺入RRV糖蛋白的效率与VSV-G相当。两种假型具有相似的物理滴度,但具有RRV假型的感染性滴度低于VSV-G。将SFV糖蛋白掺入慢病毒载体的效率较低,导致物理和感染滴度降低。通过结合使用Polybrene和涂有CH-296重组纤连蛋白片段的平板,可以显着提高VSV-G-,RRV-和SFV假型慢病毒载体向贴壁细胞系的转导率。总之,我们的数据表明RRV和SFV糖蛋白可能适合作为VSV-G的替代品,用于假病毒慢病毒载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号